We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib (PA32540-109)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00700687
First Posted: June 19, 2008
Last Update Posted: January 12, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
POZEN
June 4, 2008
June 19, 2008
January 12, 2009
June 2008
July 2008   (Final data collection date for primary outcome measure)
Lanza scores [ Time Frame: entire course of study ]
Same as current
Complete list of historical versions of study NCT00700687 on ClinicalTrials.gov Archive Site
safety of three treatments [ Time Frame: entrie course of study ]
Same as current
Not Provided
Not Provided
 
Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib
Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib
We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments
Not Provided
Interventional
Phase 1
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Healthy
  • Drug: PA32540
    aspirin/omeprazole
  • Drug: PA32540 and celecoxib
    aspirin/omeprazole and celecoxib
  • Drug: aspirin and [NSAID]
    aspirin and [NSAID]
  • Experimental: 1
    PA32540
    Intervention: Drug: PA32540
  • Experimental: 2
    PA32540 and celecoxib
    Intervention: Drug: PA32540 and celecoxib
  • Active Comparator: 3
    aspirin and celecoxib
    Intervention: Drug: aspirin and [NSAID]
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
90
July 2008
July 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy male or non-pregnant female subjects greater than or equal to 50 years as well as other standard inclusion criteria for a study of this nature

Exclusion Criteria:

  • Standard exclusion criteria for a study of this nature
Sexes Eligible for Study: All
50 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00700687
PA32540-109
No
Not Provided
Not Provided
Eric Orlemans, POZEN
POZEN
Not Provided
Not Provided
POZEN
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP